Printer Friendly
The Free Library
14,537,187 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Allergan Will Acquire Lens Care Business From Pilkington Acquisition Expands Lens Care Business in Japan.


IRVINE, Calif.--(BUSINESS WIRE)--Nov. 28, 1995--Allergan Inc. (NYSE NYSE

See: New York Stock Exchange
:AGN AGN Again (Amateur Radio)
AGN Active Galactic Nucleus
AGN Acute Glomerulonephritis
AGN Accountants Global Network
AGN Air Gabon (ICAO code) 
) Tuesday announced that it has entered into an agreement to acquire the worldwide contact lens contact lens, thin plastic lens worn between the eye and eyelid that may be used instead of eyeglasses. Actors, models, and others wear them for appearance, and athletes use them for safety and convenience.  care business of Pilkington Barnes Hind.

Terms of the agreement were not disclosed. Closing of the purchase is subject to certain regulatory clearances in Japan.

"This is a strategic geographic acquisition that provides critical mass to our contact lens care business in Japan," said Allergan President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  William C. Shepherd. "Since 70 percent of the revenues of the business acquired are in Japan, it will approximately double our lens care business in this market."

Included in the acquisition is Consept(R) F Cleaning and Disinfecting System. Consept(R) F is a cold chemical (peroxide) disinfection disinfection,
n the process of destroying pathogenic organisms or rendering them inert.

disinfection, full oral cavity,
n a procedure used to reduce active periodontal disease, usually completed within a certain short time frame.
 product for soft contact lenses. It is the only approved non-heat disinfection system for soft contact lenses in the Japanese market.

"The soft lens care market in Japan is rapidly emerging," added Shepherd. "The soft lens disinfection market in Japan has the potential to grow significantly by the year 2000."

Today there are approximately 9 million contact lens wearers in Japan but less than 40 percent wear soft contact lenses. The trend in the Japanese market continues to be a shift from Rigid Gas Permeable (RGP RGP Rigid Gas Permeable (contact lens material)
RGP Redemption Grace Period (domain name registrar management)
RGP Rice Genome Project
RGP Raster Graphics Processor
RGP Rapport Général sur la Pauvreté
) contact lenses to soft contact lenses. Additionally, the trend in soft lens care in the Japanese market continues to be moving from heat disinfection to cold chemical (peroxide) systems.

In August of this year, Allergan increased its current holding to 100 percent in Santen-Allergan, a joint venture company established in 1974 to manufacture, import and sell contact lens care products in the Japanese market.

Allergan, Inc., a global health care company headquartered in Irvine, California, develops, manufactures, and markets specialty therapeutic products for eye and skin care and neuromuscular neuromuscular /neu·ro·mus·cu·lar/ (-mus´ku-ler) pertaining to nerves and muscles, or to the relationship between them.

neu·ro·mus·cu·lar
adj.
1.
 disorders. A technology-driven company, Allergan is working to be the partner of choice for ever better specialty health care.

CONTACT: Allergan Inc.

Jeff D'Eliscu, 714/752-4636 work

714/675-9475, home
COPYRIGHT 1995 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1995, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Nov 28, 1995
Words:326
Previous Article:Saunders to retire as president & general manager of KXTV in Sacramento; Clements-Hill promoted.
Next Article:New England Electric declares dividend.
Topics:



Related Articles
Staar Surgical Co. (Contracts)
Allergan prevails in Staar Surgical lawsuit.
Change in Santen-Allergan share holdings.
Allergan second quarter sales grow 17 percent; $50 million contributed to ALRT.
Allergan completes acquisition of Pilkington Barnes Hind.
Allergan reports 13 percent sales growth for the year; board of directors declares quarterly dividend.
Wesley-Jessen to acquire Pilkington Barnes Hind.
Visx, Allergan Lead Vision Industry Stocks With Strong Performance Through 3Q 1998.
ALLERGAN LICENSES QUINOLONE ANTIBIOTIC FROM KYORIN.
Pyott's Voyage in Lilliput.(David E.I. Pyott, chief executive of Allergan)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles